Home > Insider Trading > Filing (0000950170-25-072914)

Filing Details

Accession Number:: 0000950170-25-072914
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-15 17:54:39
Reporting Period:: 2025-05-13

Filing Date:: 2025-05-15
Accepted Time:: 2025-05-15 17:54:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
860730	Hca Healthcare Inc.	HCA	Services-General Medical & Surgical Hospitals, Nec (8062)	273865930

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513235	M Jon Foster	One Park Plaza Nashville TN 37203	Evp And Coo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-05-13	15,698	$369.32	12,646	No	4	S	Direct
Common Stock	Disposition	2025-05-13	1,080	$0.00	11,566	No	4	G	Direct
Common Stock	Acquisiton	2025-05-13	1,080	$0.00	67,595	No	4	G	Indirect	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
Common Stock	Disposition	2025-05-13	2,075	$0.00	15,925	No	4	G	Indirect	By Spouse
Common Stock	Acquisiton	2025-05-13	2,075	$0.00	56,383	No	4	G	Indirect	By LCF Trust (Reporting Person, Trustee)
Common Stock	Disposition	2025-05-13	15,925	$367.20	0	No	4	J	Indirect	By Spouse
Common Stock	Acquisiton	2025-05-13	15,925	$367.20	72,308	No	4	J	Indirect	By LCF Trust (Reporting Person, Trustee)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	G	Direct
No	4	G	Indirect	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
No	4	G	Indirect	By Spouse
No	4	G	Indirect	By LCF Trust (Reporting Person, Trustee)
No	4	J	Indirect	By Spouse
No	4	J	Indirect	By LCF Trust (Reporting Person, Trustee)

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,985	Indirect	By JMF Family Trust (Spouse, Trustee)

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.80 to $370.56, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Pursuant to a power of substitution, on May 13, 2025, the Reporting Person's spouse transferred 15,925 shares of common stock of the Issuer to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $367.195 (the average of the high and low prices of shares of common stock of the Issuer on May 13, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.
On each of November 18, 2024 and February 18, 2025, a Form 4 was filed for the Reporting Person, and, due to administrative error, the indirect beneficial ownership held by the Reporting Person in the JMF Family Trust, which had been included in prior reports, was omitted. The beneficial ownership has been correctly reflected herein.